Viral Vector Mobilan Offers a New Approach for Cancer Immunotherapy,...

Preclinical study in prostate cancer shows that virus-based drug candidate Mobilan may improve anticancer vaccination(PRWeb October 24, 2017)Read the full story at http://www.prweb.com/releases/2017/10/prweb14840823.htm

Source: PRWeb: Medical Pharmaceuticals - October 24, 2017 Category: Pharmaceuticals Source Type: news